{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:41:15Z","timestamp":1793810475551,"version":"4.6.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002957","name":"Technische Universit\u00e4t Dresden","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>The burden of Respiratory Syncytial Virus (RSV) associated adult emergency department visits in comparison to other respiratory viruses like Influenza and SARS-CoV-2 remains less studied.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We performed a prospective observational study to describe prevalence, severity and risk factors of RSV infection, proven by polymerase chain reaction from nasopharyngeal or pharyngeal swabs, in consecutive adult patients presenting to the emergency ward of the University Hospital Dresden with a working diagnosis of acute respiratory tract infection during the winter season between October 1st 2023 and April 15th 2024.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>1764 adults (56.3% male) between 18 and 101 years old (median age 69 years) were included in the analysis. 477 patients (27.1%) tested positive for viral infection; 284 (16.2%) with SARS-CoV-2 (median age 79 years), 147 (8.4%) with Influenza A or B (median age 56 years) and 38 (2.2%) with RSV A or B (median age 79 years). In 8 patients (0.5%) a co-infection with two viruses was detected. In the RSV cohort any oxygen support was significantly higher (63.2%) compared to the Influenza (34.0%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and SARS-CoV-2 (41.5%, <jats:italic>p<\/jats:italic>\u2009=\u20090.012) cohorts. In-hospital mortality was considerable especially for RSV with 7.9% compared to Influenza (2.7%, <jats:italic>p<\/jats:italic>\u2009=\u20090.138) and SARS-CoV-2 (5.6%, <jats:italic>p<\/jats:italic>\u2009=\u20090.580).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>RSV was less frequent in adults presenting to the emergency department during the 2023\/24 season compared to SARS-CoV-2 and Influenza, but patients needed a higher level of respiratory support. Also, in-hospital mortality was considerable, making RSV-infections a relevant pathogen in adult patients presenting with respiratory tract infection to an emergency department.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12985-025-02692-z","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T04:48:56Z","timestamp":1742186936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Burden and characteristics of Respiratory Syncytial Virus-associated respiratory tract infections in adult patients in the winter season 2023\/2024 at the conservative emergency department of the university hospital in Dresden"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2751-4763","authenticated-orcid":false,"given":"J","family":"Ronczka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"von Bonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Laubner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Hochauf-Stange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Rank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5367-7932","authenticated-orcid":false,"given":"M","family":"Kolditz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"issue":"10","key":"2692_CR1","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S2213-2600(24)00255-8","volume":"12","author":"JG Wildenbeest","year":"2024","unstructured":"Wildenbeest JG, Lowe DM, Standing JF, Butler CC. Respiratory syncytial virus infections in adults: a narrative review. Lancet Respir Med. 2024;12(10):822\u201336.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"2692_CR2","doi-asserted-by":"publisher","first-page":"e13031","DOI":"10.1111\/irv.13031","volume":"17","author":"M Savic","year":"2023","unstructured":"Savic M, Penders Y, Shi T, Branche A, Pir\u00e7on JY. Respiratory syncytial virus disease burden in adults aged 60 years and older in high-income countries: A systematic literature review and meta-analysis. Influenza Other Respir Viruses. 2023;17(1):e13031.","journal-title":"Influenza Other Respir Viruses"},{"key":"2692_CR3","doi-asserted-by":"crossref","unstructured":"Quarg C, J\u00f6rres R, Engelhardt S, Alter P, Budweiser S. Characteristics and outcomes of patients hospitalized for infection with influenza, SARS-CoV-2 or respiratory syncytial virus in the season 2022\/2023 in a large German primary care centre. Eur J Med Res [Internet]. 2023 Jun 12 [cited 2024 Oct 6];28(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38053110\/","DOI":"10.1186\/s40001-023-01482-z"},{"key":"2692_CR4","doi-asserted-by":"crossref","unstructured":"Fistera D, Cm K, Rk M, Elsner C, Dittmer U, Taube C et al. Adult patients with severe respiratory syncytial virus infections in the emergency department. Medicine (Baltimore) [Internet]. 2024 Sep 27 [cited 2024 Oct 7];103(39). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39331940\/","DOI":"10.1097\/MD.0000000000039265"},{"issue":"6","key":"2692_CR5","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jamainternmed.2024.0212","volume":"184","author":"RC Woodruff","year":"2024","unstructured":"Woodruff RC, Melgar M, Pham H, Sperling LS, Loustalot F, Kirley PD, et al. Acute cardiac events in hospitalized older adults with respiratory syncytial virus infection. JAMA Intern Med. 2024;184(6):602\u201311.","journal-title":"JAMA Intern Med"},{"issue":"11","key":"2692_CR6","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130\u20139.","journal-title":"Med Care"},{"issue":"6","key":"2692_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jacc.2022.11.044","volume":"81","author":"RC Woodruff","year":"2023","unstructured":"Woodruff RC, Garg S, George MG, Patel K, Jackson SL, Loustalot F, et al. Acute cardiac events during COVID-19-Associated hospitalizations. J Am Coll Cardiol. 2023;81(6):557\u201369.","journal-title":"J Am Coll Cardiol"},{"key":"2692_CR8","doi-asserted-by":"crossref","unstructured":"Santus P, Radovanovic D, Gismondo Mr R, Sg, Lombardi A, Danzo F et al. Respiratory syncytial virus burden and risk factors for severe disease in patients presenting to the emergency department with flu-like symptoms or acute respiratory failure. Respir Med [Internet]. 2023 Nov [cited 2024 Oct 6];218. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37683776\/","DOI":"10.1016\/j.rmed.2023.107404"},{"issue":"18","key":"2692_CR9","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.121.057042","volume":"144","author":"O Fr\u00f6bert","year":"2021","unstructured":"Fr\u00f6bert O, G\u00f6tberg M, Erlinge D, Akhtar Z, Christiansen EH, MacIntyre CR, et al. Influenza vaccination after myocardial infarction: A randomized, Double-Blind, Placebo-Controlled, multicenter trial. Circulation. 2021;144(18):1476\u201384.","journal-title":"Circulation"},{"issue":"7","key":"2692_CR10","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s40121-024-00974-7","volume":"13","author":"E Ubamadu","year":"2024","unstructured":"Ubamadu E, Betancur E, Gessner BD, Menon S, Vroling H, Curcio D, et al. Respiratory syncytial virus sequelae among adults in High-Income countries: A systematic literature review and Meta-analysis. Infect Dis Ther. 2024;13(7):1399\u2013417.","journal-title":"Infect Dis Ther"},{"issue":"3","key":"2692_CR11","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/cid\/ciad627","volume":"78","author":"S Carazo","year":"2024","unstructured":"Carazo S, Guay CA, Skowronski DM, Amini R, Charest H, De Serres G, et al. Influenza hospitalization burden by subtype, age, comorbidity, and vaccination status: 2012\u20132013 to 2018\u20132019 seasons, Quebec, Canada. Clin Infect Dis Off Publ Infect Dis Soc Am. 2024;78(3):765\u201374.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"3","key":"2692_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/irv.12234","volume":"8","author":"K Widmer","year":"2014","unstructured":"Widmer K, Griffin MR, Zhu Y, Williams JV, Talbot HK. Respiratory syncytial virus- and human metapneumovirus-associated emergency department and hospital burden in adults. Influenza Other Respir Viruses. 2014;8(3):347\u201352.","journal-title":"Influenza Other Respir Viruses"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02692-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02692-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02692-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T04:48:58Z","timestamp":1742186938000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02692-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2692"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02692-z","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JR has received support from AstraZeneca to attend a conference. MK reports payment or honoraria for lectures from AstraZeneca, Berlin-Chemie, Boehringer Ingelheim, Gilead, GSK, Insmed, Pfizer; and participation in advisory boards for AstraZeneca, Gilead, GSK, MSD, and Insmed; all outside of the submitted work.SvB, KHS, AL and MR do not have conflicts of interest to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the ethics committee of the TU Dresden (BO-EK-161042023) and waiver of informed consent was granted. The study was registered with the German Clinical Trials Register (\u201cDeutsches Register Klinischer Studien\u201d \u2013 DRKS) under the number DRKS00032559.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval consent to participate"}}],"article-number":"76"}}